BANK VONTOBEL/CALL/PFIZER INC/28/0.1/20.09.24 Share Price

Warrant

DE000VM67WC5

Real-time Boerse Frankfurt Warrants 13:01:15 04/07/2024 BST
0.115 EUR +11.65% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/28/0.1/20.09.24
Current month-12.71%
1 month-54.02%
Date Price Change
04/07/24 0.115 +11.65%
03/07/24 0.103 -8.85%
02/07/24 0.113 -16.91%
01/07/24 0.136 +15.25%
28/06/24 0.118 +1.72%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 01:01 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM67WC
ISINDE000VM67WC5
Date issued 18/12/2023
Strike 28 $
Maturity 20/09/2024 (78 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.39
Lowest since issue 0.077
Delta0.48x
Omega 10.11
Premium5.84x
Gearing21.02x
Moneyness 0.9893
Difference Strike 0.3 $
Difference Strike %+1.07%
Spread 0.01
Spread %7.87%
Theoretical value 0.1160
Implied Volatility 28.36 %
Total Loss Probability 57.04 %
Intrinsic value 0.000000
Present value 0.1160
Break even 29.25 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus